# CEFEPIME/ENMETAZOBACTAM: Physicochemical Stability of a Novel β-Lactam/β-Lactamase Inhibitor Combination in Syringes and Elastomeric Devices

**Authors:** Akim Chayem, Juan Quevedo, Sandrine Cure, Noëlle Jemmely, Béatrice Demore, Beatriz Esteban-Cartelle, Brayan J. Anaya, Gabriel A. Peñalver, Dolores R. Serrano, Elise D’Huart

PMC · DOI: 10.3390/antibiotics15020114 · Antibiotics · 2026-01-23

## TL;DR

This study examines the stability of a new antibiotic combination in different storage containers and conditions for potential use in long-term treatments.

## Contribution

The study provides new stability data for cefepime/enmetazobactam in various infusion devices and storage conditions.

## Key findings

- FEP/META retained over 90% of its initial concentration for up to 24 hours in certain conditions.
- Stability was enhanced in silicone devices with D5W at all concentrations.
- The solution was chemically stable for 24 hours in polyisoprene devices at low temperatures.

## Abstract

Background: Cefepime/enmetazobactam (FEP/META) is a novel fixed-dose β-lactam/β-lactamase inhibitor combination. The objective was to study the physicochemical stability of the approved daily dose in polypropylene syringes and elastomeric devices over a 24 or 72 h period to understand the feasibility of using FEP/META in prolonged infusions and its use for outpatient parenteral antibiotic therapy (OPAT). Methods: Solutions of FEP/META were prepared in 0.9% NaCl or 5% dextrose (D5W) and stored in syringes (6 g/1.5 g/48 mL) or silicone and polyisoprene elastomeric devices (EDs) at 6 g/1.5 g/120 mL and 6 g/1.5 g/240 mL: syringes were tested at 22–25 °C over a 24 h period, polyisoprene EDs at 2–8 °C over 72 h period, and silicone and polyisoprene EDs at 32 °C over a 24 h period. The solution was considered stable if it retained more than 90% of its initial concentration (Ci), no pH variation (±1 unit), no significant visual change, and with compliant subvisual examination. Liquid Chromatography–Electrospray Ionization–Quadrupole Time-of-Flight–Mass Spectrometry was utilized to identify intermediate degradation products. Results: At the daily dose, FEP/META retained >90% of its Ci up to 12 h in 0.9% NaCl and 24 h in D5W when stored in syringes. In silicone ED, stability was enhanced up to 24 h in D5W at all concentrations. The solution was chemically stable for 24 h when stored in polyisoprene ED in 0.9% NaCl at 2–8 °C. Conclusions: FEP/META combination showed prolonged stability with physicochemical integrity up to 12–24 h in all containers and conditions. It appears to be stable for prolonged infusions and for OPAT.

## Linked entities

- **Chemicals:** Cefepime (PubChem CID 5479537), Enmetazobactam (PubChem CID 23653540), 0.9% NaCl (PubChem CID 5234), 5% dextrose (PubChem CID 22814120)

## Full-text entities

- **Diseases:** ill (MESH:D002908), cUTIs (MESH:D014552), HAP (MESH:D000077299), infections (MESH:D007239), VAP (MESH:D053717), pyelonephritis (MESH:D011704), OPAT (MESH:D004761), bacteraemia (MESH:C531821), injury to (MESH:D014947), critically ill (MESH:D016638)
- **Chemicals:** D5W (MESH:D005947), beta-lactam (MESH:D047090), H (MESH:D006859), polypropylene (MESH:D011126), triazole (MESH:D014230), 5-HMF (MESH:C008046), arginine (MESH:D001120), Enmetazobactam (MESH:C000656730), cephalosporin (MESH:D002511), imine (MESH:D007097), penicillanic acid sulfone (MESH:D013407), FEP-META (-), H2O2 (MESH:D006861), polyethylene (MESH:D020959), NaOH (MESH:D012972), silicone (MESH:D012828), tazobactam (MESH:D000078142), HCl (MESH:D006851), meropenem (MESH:D000077731), cefepime (MESH:D000077723), H2O (MESH:D014867), acetonitrile (MESH:C032159), beta-lactam antibiotics (MESH:D008997), N-Methylpyrrolidine (MESH:C054965), Formic acid (MESH:C030544), FEP (MESH:D011138), methanol (MESH:D000432), NaCl (MESH:D012965)
- **Species:** Acinetobacter baumannii (species) [taxon 470], Homo sapiens (human, species) [taxon 9606], Enterobacterales (order) [taxon 91347], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937291/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937291/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937291/full.md

---
Source: https://tomesphere.com/paper/PMC12937291